Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 233 Head and Neck Neoplasms 150 Squamous Cell Carcinoma of Head and Neck 136 Stomach Neoplasms 117 Lung Neoplasms 109 Esophageal Neoplasms 90 Uterine Cervical Neoplasms 72 Neoplasms 67 Urinary Bladder Neoplasms 56 Breast Neoplasms 48 Ovarian Neoplasms 46 Esophageal Squamous Cell Carcinoma 45 Pancreatic Neoplasms 44 Small Cell Lung Carcinoma 42 Neoplasm Metastasis 40 Adenocarcinoma Of Esophagus 38 Carcinoma, Squamous Cell 33 Carcinoma, Ovarian Epithelial 32 Mesothelioma, Malignant 30 Parkinson Disease 4, Autosomal Dominant Lewy Body 28 Lymphoma 28 Adenocarcinoma of Lung 25 Sarcoma 24 Cholangiocarcinoma 24 Nasopharyngeal Carcinoma 22 Carcinoma 22 Unspecified Adult Solid Tumor, Protocol Specific 21 Neuroblastoma 21 Gallbladder Neoplasms 21 Central Nervous System Neoplasms 21

Interventions

S 1 (combination) 2 Gemcitabine 2 lorlatinib 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Non-Small Cell Lung Cancer × Cisplatin × Clear all

NCT00349219 2016-01-15

TORCH

National Cancer Institute, Naples

Phase 3 Completed

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡